HKSE - Delayed Quote HKD
Clover Biopharmaceuticals, Ltd. (2197.HK)
0.199
-0.004
(-1.97%)
At close: May 9 at 3:19:05 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-288,486
-288,486
-727,878
-1,690,809
-917,749
Investing Cash Flow
3,168
3,168
-6,161
-37,506
112,124
Financing Cash Flow
-51,499
-51,499
-142,408
483,143
3,057,173
End Cash Position
401,243
401,243
735,864
1,607,409
2,767,371
Capital Expenditure
-1,628
-1,628
-9,176
-105,560
-80,316
Issuance of Capital Stock
5
5
84
453,155
3,765,561
Issuance of Debt
80,277
80,277
460,792
293,833
0
Repayment of Debt
-314,609
-314,609
-444,591
0
--
Repurchase of Capital Stock
--
--
--
0
-530,179
Free Cash Flow
-290,114
-290,114
-737,054
-1,796,369
-998,065
12/31/2021 - 11/5/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6826.HK Shanghai Haohai Biological Technology Co., Ltd.
23.300
-1.69%
1228.HK CANBRIDGE-B
0.135
-3.57%
2257.HK Sirnaomics Ltd.
3.050
-0.33%
2256.HK Abbisko Cayman Limited
7.830
+1.69%
0690.HK UNI-BIO GROUP
0.071
-8.97%
6660.HK AIM Vaccine Co., Ltd.
3.500
-3.31%
2157.HK Lepu Biopharma Co., Ltd.
4.490
-3.44%
2137.HK Brii Biosciences Limited
1.900
-1.04%
2126.HK JW (Cayman) Therapeutics Co. Ltd
1.600
+7.38%
ESLA Estrella Immunopharma, Inc.
1.0300
-7.21%